Home Pyridines 115436-72-1
115436-72-1,MFCD14584874
Catalog No.:AA000FX0

115436-72-1 | sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
98%
in stock  
$6.00   $4.00
- +
1g
97%
in stock  
$32.00   $23.00
- +
5g
97%
in stock  
$96.00   $67.00
- +
25g
98%
in stock  
$411.00   $288.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA000FX0
Chemical Name:
sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate
CAS Number:
115436-72-1
Molecular Formula:
C7H10NNaO7P2
Molecular Weight:
305.0941
MDL Number:
MFCD14584874
SMILES:
OC(P(=O)(O)O)(P(=O)(O)[O-])Cc1cccnc1.[Na+]
Properties
Computed Properties
 
Complexity:
375  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
4  
Undefined Atom Stereocenter Count:
1  

Literature

Title: Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro).

Journal: European journal of cancer (Oxford, England : 1990) 20121101

Title: Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study.

Journal: Spine 20121101

Title: Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20121001

Title: Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial.

Journal: Journal of cancer research and clinical oncology 20120901

Title: Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates.

Journal: Journal of bone and mineral metabolism 20120901

Title: Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study.

Journal: Bone 20120901

Title: Risedronate-associated scleritis: a case report and review of the literature.

Journal: Clinical rheumatology 20120901

Title: Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801

Title: The association between automatic generic substitution and treatment persistence with oral bisphosphonates.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801

Title: The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801

Title: Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.

Journal: Journal of Crohn's & colitis 20120801

Title: Lipid profiles within the SABRE trial of anastrozole with and without risedronate.

Journal: Breast cancer research and treatment 20120801

Title: Effect of risedronate on bone in renal transplant recipients.

Journal: Journal of the American Society of Nephrology : JASN 20120801

Title: Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer.

Journal: Journal of bone and mineral metabolism 20120701

Title: Risedronate improves bone mineral density in Crohn's disease: a complementary mechanism.

Journal: Journal of Crohn's & colitis 20120701

Title: Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?

Journal: The Journal of bone and joint surgery. British volume 20120701

Title: Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.

Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514

Title: Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis.

Journal: Current medical research and opinion 20120501

Title: Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120501

Title: Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis.

Journal: Rheumatology international 20120401

Title: [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection].

Journal: Se pu = Chinese journal of chromatography 20120401

Title: Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America 20120313

Title: Osteoporosis, osteopenia and fracture risk: widening the therapeutic horizons.

Journal: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20120308

Title: Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

Title: Adherence to osteoporosis medications amongst Singaporean patients.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

Title: Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

Title: Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Journal: Current medical research and opinion 20120301

Title: Paget disease of bone - an update.

Journal: Australian family physician 20120301

Title: Immediate loading in mandible full-arch: pilot study in patients with osteoporosis in bisphosphonate therapy.

Journal: The Journal of oral implantology 20120201

Title: Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201

Title: Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120201

Title: Three-year experience with risedronate therapy for patients with an increased fracture risk: assessment of proximal femoral bone density and geometry by DXA.

Journal: Clinical drug investigation 20120201

Title: Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120115

Title: Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

Title: Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

Title: Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

Title: Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.

Journal: Bone 20120101

Title: Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate.

Journal: Bone 20120101

Title: Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

Title: Heel ultrasound can assess maintenance of bone mass in women with breast cancer.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20120101

Title: Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.

Journal: PloS one 20120101

Title: Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis.

Journal: Biological & pharmaceutical bulletin 20120101

Title: Atypical bilateral pedicle fracture in long-term bisphosphonate therapy.

Journal: Spine 20111215

Title: Bisphosphonate treatment delays stress fracture remodeling in the rat ulna.

Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20111201

Title: The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111201

Title: Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial.

Journal: Journal of neurology, neurosurgery, and psychiatry 20111201

Title: Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20111201

Title: Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate.

Journal: Bone 20111201

Title: Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: role of the Akt pathway and the ERK/Bim axis.

Journal: Arthritis and rheumatism 20111201

Title: Identifying common trajectories of joint space narrowing over two years in knee osteoarthritis.

Journal: Arthritis care & research 20111201

Title: Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogen-containing bisphosphonate in rats. Comparison with alendronate and minodronate.

Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20111201

Title: Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.

Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111201

Title: Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101

Title: Effect of stopping risedronate after long-term treatment on bone turnover.

Journal: The Journal of clinical endocrinology and metabolism 20111101

Title: Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease.

Journal: European journal of gastroenterology & hepatology 20111101

Title: Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin.

Journal: International journal of pharmaceutics 20111031

Title: The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.

Journal: The Journal of bone and joint surgery. American volume 20111019

Title: Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover.

Journal: Bone 20111001

Title: Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.

Journal: Journal of clinical pharmacy and therapeutics 20111001

Title: Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost.

Journal: Journal of managed care pharmacy : JMCP 20111001

Title: Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study.

Journal: Journal of bone and mineral metabolism 20110901

Title: Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study.

Journal: Prostate cancer and prostatic diseases 20110901

Title: Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36.

Journal: Journal of bone and mineral metabolism 20110901

Title: Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).

Journal: Calcified tissue international 20110901

Title: In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.

Journal: Current medical research and opinion 20110901

Title: What is the optimal duration of bisphosphonate therapy?

Journal: Cleveland Clinic journal of medicine 20110901

Title: Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-κB ligand and apoptosis in mesenchymal stem cells.

Journal: Basic & clinical pharmacology & toxicology 20110801

Title: Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.

Journal: Bone 20110701

Title: Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis.

Journal: Journal of bone and mineral metabolism 20110701

Title: Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110701

Title: Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study.

Journal: Transplant international : official journal of the European Society for Organ Transplantation 20110701

Title: Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.

Journal: Bone 20110701

Title: Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study.

Journal: The Journal of clinical endocrinology and metabolism 20110701

Title: Simultaneous bilateral subtrochanteric fractures following risedronate therapy.

Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20110701

Title: Shotgun proteomics analysis reveals new unsuspected molecular effectors of nitrogen-containing bisphosphonates in osteocytes.

Journal: Journal of proteomics 20110610

Title: Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures.

Journal: Calcified tissue international 20110601

Title: Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis.

Journal: Clinical endocrinology 20110601

Title: Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin.

Journal: Panminerva medica 20110601

Title: Crystallization products of risedronate with carbohydrates and their substituted derivatives.

Journal: Molecules (Basel, Switzerland) 20110504

Title: Effects of risedronate on bone marrow adipocytes in postmenopausal women.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501

Title: In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum.

Journal: Antimicrobial agents and chemotherapy 20110501

Title: Dose-dependent differential effects of risedronate on gene expression in osteoblasts.

Journal: Biochemical pharmacology 20110415

Title: Osteoporosis medication and reduced mortality risk in elderly women and men.

Journal: The Journal of clinical endocrinology and metabolism 20110401

Title: In brief: delayed-release risedronate (Atelvia).

Journal: The Medical letter on drugs and therapeutics 20110321

Title: Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

Title: Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

Title: Characterization of a new solvate of risedronate.

Journal: Journal of pharmaceutical sciences 20110301

Title: Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats.

Journal: American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 20110301

Title: Osteonecrosis of the jaw and the role of macrophages.

Journal: Journal of the National Cancer Institute 20110202

Title: [Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain].

Journal: Atencion primaria 20110201

Title: A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres.

Journal: Journal of pharmaceutical sciences 20110201

Title: Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.

Journal: Bone 20110201

Title: Treatments for osteoporosis in people with a disability.

Journal: PM & R : the journal of injury, function, and rehabilitation 20110201

Title: Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational study.

Journal: Journal of bone and mineral metabolism 20110101

Title: The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer.

Journal: Breast cancer research and treatment 20110101

Title: When do bisphosphonates make the most sense?

Journal: The Journal of family practice 20110101

Title: A case of Marinesco-Sjögren syndrome: MRI observations of skeletal muscles, bone metabolism, and treatment with testosterone and risedronate.

Journal: Internal medicine (Tokyo, Japan) 20110101

Title: [Bilateral pathological sub-trochanteric fracture in a long-term biphosphonate user].

Journal: Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca 20110101

Title: Multiple vertebral compression fractures associated with post partum osteoporosis.

Journal: Journal of back and musculoskeletal rehabilitation 20110101

Title: The assessment of regional skeletal metabolism: studies of osteoporosis treatments using quantitative radionuclide imaging.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101

Title: The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial.

Journal: The Kurume medical journal 20110101

Title: Stress fractures: diagnosis, treatment, and prevention.

Journal: American family physician 20110101

Title: Going on a drug holiday?

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101

Title: Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study.

Journal: Life sciences 20101218

Title: Risedronate metal complexes potentially active against Chagas disease.

Journal: Journal of inorganic biochemistry 20101201

Title: Response of postpoliomyelitis patients to bisphosphonate treatment.

Journal: PM & R : the journal of injury, function, and rehabilitation 20101201

Title: Outcome of patients with early breast cancer receiving nitrogen-containing bisphosphonates: a comparative analysis from the Metropolitan Detroit Cancer Surveillance System.

Journal: Clinical breast cancer 20101201

Title: Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer.

Journal: BJU international 20101101

Title: Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101101

Title: Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women.

Journal: Calcified tissue international 20101101

Title: How to prevent glucocorticoid-induced osteoporosis.

Journal: Cleveland Clinic journal of medicine 20101101

Title: The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation.

Journal: Spine 20101015

Title: Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101009

Title: Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase.

Journal: Bioorganic & medicinal chemistry letters 20101001

Title: Risk of upper gastrointestinal tract events in risedronate users switched to alendronate.

Journal: Calcified tissue international 20101001

Title: Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.

Journal: International journal of rheumatic diseases 20101001

Title: High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment.

Journal: Journal of bone and mineral metabolism 20100901

Title: In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat.

Journal: Arthritis and rheumatism 20100901

Title: [Dementia and fracture].

Journal: Clinical calcium 20100901

Title: [Jaw osteonecrosis induced by oral biphosphonates: 12 cases].

Journal: Revue de stomatologie et de chirurgie maxillo-faciale 20100901

Title: The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100801

Title: Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.

Journal: Acta orthopaedica 20100801

Title: Effect of risedronate on bone resorption during consolidation phase of distraction osteogenesis: a rabbit model.

Journal: Journal of orthopaedic surgery (Hong Kong) 20100801

Title: Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice.

Journal: Journal of bone and mineral metabolism 20100701

Title: Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget's disease of bone.

Journal: Journal of bone and mineral metabolism 20100701

Title: How do bisphosphonates inhibit bone metastasis in vivo?

Journal: Neoplasia (New York, N.Y.) 20100701

Title: [Osteoporosis management in general practice. Preventing spontaneous bone fractures].

Journal: MMW Fortschritte der Medizin 20100701

Title: Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients.

Journal: Transplantation 20100627

Title: Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601

Title: Effects of treatment with risedronate and alfacalcidol on progression of atherosclerosis in postmenopausal women with type 2 diabetes mellitus accompanied with osteoporosis.

Journal: The American journal of the medical sciences 20100601

Title: Risedronate-induced arthritis.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100601

Title: Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid.

Journal: Journal of medicinal chemistry 20100513

Title: Atypical femoral fractures and bisphosphonate use.

Journal: The New England journal of medicine 20100513

Title: An in vitro assay to measure targeted drug delivery to bone mineral.

Journal: ChemMedChem 20100503

Title: Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501

Title: How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care.

Journal: Journal of the American Dental Association (1939) 20100501

Title: Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100401

Title: Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis.

Journal: Aging clinical and experimental research 20100401

Title: Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.

Journal: Journal of the American Geriatrics Society 20100401

Title: Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100301

Title: Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100301

Title: The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100301

Title: The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: a 2-year trial.

Journal: Bone 20100301

Title: Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

Journal: Bone 20100301

Title: Effect of osteoporosis treatment on mortality: a meta-analysis.

Journal: The Journal of clinical endocrinology and metabolism 20100301

Title: Response to oral bisphosphonates in subgroups of younger and older postmenopausal women.

Journal: Journal of women's health (2002) 20100301

Title: Effects of risedronate on osteoarthritis of the knee.

Journal: Yonsei medical journal 20100301

Title: Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100301

Title: Intravenous zoledronic acid: what are the indications for male osteoporosis?

Journal: Current osteoporosis reports 20100301

Title: Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220

Title: Unusual mid-shaft fractures during long-term bisphosphonate therapy.

Journal: Clinical endocrinology 20100201

Title: Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years.

Journal: Bone 20100201

Title: Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100201

Title: Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100201

Title: A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101

Title: Risedronate reduces intracortical porosity in women with osteoporosis.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101

Title: Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice.

Journal: Journal of bone and mineral metabolism 20100101

Title: Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations.

Journal: Bone 20100101

Title: Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.

Journal: Bone 20100101

Title: Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.

Journal: Bone 20100101

Title: Differences between bisphosphonates in binding affinities for hydroxyapatite.

Journal: Journal of biomedical materials research. Part B, Applied biomaterials 20100101

Title: Risedronate on 2 consecutive days a month reduced vertebral fracture risk at 1year compared with historical placebo.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20100101

Title: Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone.

Journal: Calcified tissue international 20100101

Title: [Diagnosis and treatment of osteoporosis in persons aged more than 75 years].

Journal: Revista espanola de geriatria y gerontologia 20100101

Title: Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study.

Journal: Internal medicine (Tokyo, Japan) 20100101

Title: Analysis of risedronate and related substances by ion-pair reversed-phase high-performance liquid chromatography with evaporative light-scattering detection.

Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101

Title: Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.

Journal: Breast cancer research : BCR 20100101

Title: Challenges in clinical patient management.

Journal: Cancer investigation 20100101

Title: The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation.

Journal: Arthritis research & therapy 20100101

Title: Development of an ion-pair reversed-phase HPLC method with indirect UV detection for determination of phosphates and phosphites as impurities in sodium risedronate.

Journal: Journal of AOAC International 20100101

Title: Development and validation of a micellar high-performance liquid chromatographic method for determination of risedronate in raw material and in a pharmaceutical formulation: application to stability studies.

Journal: Journal of AOAC International 20100101

Title: Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome.

Journal: Internal medicine (Tokyo, Japan) 20100101

Title: Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis.

Journal: Rheumatology international 20091201

Title: Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg.

Journal: Current medical research and opinion 20091201

Title: Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091201

Title: Review of osteoporosis pharmacotherapy for geriatric patients.

Journal: The American journal of geriatric pharmacotherapy 20091201

Title: Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101

Title: Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101

Title: Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women.

Journal: Calcified tissue international 20091101

Title: A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates.

Journal: Journal of endodontics 20091101

Title: Comparative gastrointestinal safety of weekly oral bisphosphonates.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001

Title: Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001

Title: Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.

Journal: The Journal of clinical endocrinology and metabolism 20091001

Title: Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention.

Journal: Biomaterials 20091001

Title: Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090901

Title: Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790.

Journal: International journal of cancer 20090901

Title: Re 'Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors' by A. Luckish et al.

Journal: Bone 20090901

Title: Differences in persistence among different weekly oral bisphosphonate medications.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801

Title: Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy.

Journal: Current medical research and opinion 20090801

Title: [Biochemical markers of bone turnover. New aspect. Biochemical markers of bone turnover in long term treatment with bisphosphonate].

Journal: Clinical calcium 20090801

Title: Corticosteroids: no drug prevention of fractures needed.

Journal: Prescrire international 20090801

Title: Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment.

Journal: La Tunisie medicale 20090801

Title: Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.

Journal: Maturitas 20090720

Title: Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090701

Title: Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss.

Journal: Biological & pharmaceutical bulletin 20090701

Title: [Acute exacerbation of a chronic esophagitis].

Journal: Deutsche medizinische Wochenschrift (1946) 20090701

Title: DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

Title: Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

Title: RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

Title: Bone microdamage.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

Title: Risedronate recovers bone loss in patients with prostate cancer undergoing androgen-deprivation therapy.

Journal: Urology 20090601

Title: Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090601

Title: Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.

Journal: The Journal of pharmacy and pharmacology 20090601

Title: Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment.

Journal: La Tunisie medicale 20090601

Title: Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage.

Journal: Journal of biomechanics 20090511

Title: Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

Journal: Bone 20090501

Title: Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates.

Journal: Southern medical journal 20090501

Title: Osteonecrosis associated with short-term oral administration of bisphosphonate.

Journal: The Journal of prosthetic dentistry 20090501

Title: [Risedronate for treatment of osteoporosis].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20090501

Title: Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study.

Journal: Yonsei medical journal 20090430

Title: Glucocorticoid-induced osteoporosis: hope on the HORIZON.

Journal: Lancet (London, England) 20090411

Title: Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.

Journal: Lancet (London, England) 20090411

Title: Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090401

Title: Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.

Journal: Bone 20090401

Title: Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.

Journal: The Annals of pharmacotherapy 20090401

Title: Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy.

Journal: The Journal of hand surgery 20090401

Title: [Postmenopausal osteoporosis. Bisphosphonates are not all equal].

Journal: MMW Fortschritte der Medizin 20090312

Title: [Patient compliance program aids therapy success].

Journal: MMW Fortschritte der Medizin 20090312

Title: Effect of risedronate in a minipig cartilage defect model with allograft.

Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20090301

Title: Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090301

Title: LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men.

Journal: Calcified tissue international 20090301

Title: Dental implants in a patient with Paget disease under bisphosphonate treatment: a case report.

Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20090301

Title: Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates.

Journal: Journal of proteome research 20090301

Title: Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment.

Journal: Current osteoporosis reports 20090301

Title: Vitamin D status and response to treatment in post-menopausal osteoporosis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090201

Title: Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.

Journal: The American journal of medicine 20090201

Title: Monaural diplacusis with tinnitus, aural fullness, hyperacusis, and sensorineural hearing loss.

Journal: Ear, nose, & throat journal 20090201

Title: Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study.

Journal: Clinical therapeutics 20090201

Title: Paget's disease 2: exploring diagnosis, management and support strategies.

Journal: Nursing times 20090201

Title: Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090101

Title: Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.

Journal: Rheumatology international 20090101

Title: The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.

Journal: QJM : monthly journal of the Association of Physicians 20090101

Title: Effects of short-term risedronate on bone resorption and patient satisfaction in postmenopausal osteoporosis patients.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20090101

Title: [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates].

Journal: Clinical calcium 20090101

Title: New bisphosphonates and trends in drug therapy for osteoporosis: preface.

Journal: Clinical calcium 20090101

Title: [Examination of beneficial effects of risedronate in improving quality of life during long-term treatment of primary osteoporosis].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20090101

Title: Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study.

Journal: Journal of bone and mineral metabolism 20090101

Title: Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance.

Journal: Journal of bone and mineral metabolism 20090101

Title: Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.

Journal: PloS one 20090101

Title: The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study.

Journal: Journal of bone and mineral metabolism 20090101

Title: Heterotopic ossification in systemic sclerosis.

Journal: Scandinavian journal of rheumatology 20090101

Title: Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studies.

Journal: Drugs & aging 20090101

Title: Anti-fracture efficacy of risedronic acid in men: A meta-analysis of randomized controlled trials.

Journal: Clinical drug investigation 20090101

Title: Risedronate on two consecutive days per month.

Journal: Drugs & aging 20090101

Title: Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.

Journal: Clinical interventions in aging 20090101

Title: The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.

Journal: BMC musculoskeletal disorders 20090101

Title: Risedronate inhibits human osteosarcoma cell invasion.

Journal: Journal of experimental & clinical cancer research : CR 20090101

Title: Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection.

Journal: Genome biology 20090101

Title: Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease.

Journal: Aging clinical and experimental research 20090101

Title: Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.

Journal: Clinical interventions in aging 20090101

Title: Evaluation of the effect of 4 months of risedronate therapy on femoral strength using femoral strength analysis tools.

Journal: The Journal of international medical research 20090101

Title: Geranylgeranyl transferase type II inhibition prevents myeloma bone disease.

Journal: Biochemical and biophysical research communications 20081212

Title: Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081201

Title: A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues.

Journal: Journal of inorganic biochemistry 20081201

Title: [Non traumatic tooth extraction in patients treated by bisphosphonate].

Journal: Revue de stomatologie et de chirurgie maxillo-faciale 20081201

Title: Fluorescently labeled risedronate and related analogues: 'magic linker' synthesis.

Journal: Bioconjugate chemistry 20081201

Title: Evaluation by digital subtraction radiography of induced changes in the bone density of the female rat mandible.

Journal: Dento maxillo facial radiology 20081201

Title: Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode.

Journal: International journal of pharmaceutics 20081119

Title: Compatibility of risedronate sodium tablets with food thickeners.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081115

Title: Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo.

Journal: Cancer research 20081101

Title: Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization.

Journal: Arthritis and rheumatism 20081101

Title: Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies.

Journal: Micron (Oxford, England : 1993) 20081001

Title: Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081001

Title: Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone.

Journal: Bone 20081001

Title: Cutaneous vasculitis induced by risedronate.

Journal: Allergy 20081001

Title: [Efficacy and tolerability of risedronate for the treatment of osteoporosis].

Journal: Clinical calcium 20081001

Title: Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats.

Journal: Journal of periodontology 20081001

Title: Paget disease of bone: therapeutic options.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20081001

Title: [Treatment of osteoporosis in the elderly: what is the evidence?].

Journal: Tijdschrift voor gerontologie en geriatrie 20081001

Title: [Severe oesophagus injury as a complication during treatment with risedronic acid].

Journal: Nederlands tijdschrift voor geneeskunde 20080927

Title: Monthly risedronate (Actonel) for postmenopausal osteoporosis.

Journal: The Medical letter on drugs and therapeutics 20080908

Title: Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates.

Journal: Current osteoporosis reports 20080901

Title: IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole.

Journal: Expert review of anticancer therapy 20080901

Title: Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations.

Journal: The American journal of managed care 20080901

Title: Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment.

Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20080901

Title: Osteoporosis in men.

Journal: The New England journal of medicine 20080821

Title: Osteoporosis treatment and fracture incidence: the ICARO longitudinal study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080801

Title: Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors.

Journal: Bone 20080801

Title: Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women.

Journal: Bone 20080801

Title: Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.

Journal: Calcified tissue international 20080801

Title: Maximizing effectiveness of bisphosphonate therapy for osteoporosis.

Journal: Southern medical journal 20080801

Title: Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients.

Journal: Climacteric : the journal of the International Menopause Society 20080801

Title: Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs.

Journal: Journal of medicinal chemistry 20080724

Title: Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080701

Title: Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women.

Journal: British journal of clinical pharmacology 20080701

Title: Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.

Journal: The Chinese journal of physiology 20080630

Title: Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.

Journal: Osteoarthritis and cartilage 20080601

Title: Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial.

Journal: International journal of clinical practice 20080601

Title: Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601

Title: Secondary osteoporosis in long-term bedridden patients with cerebral palsy.

Journal: Pediatrics international : official journal of the Japan Pediatric Society 20080601

Title: Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis.

Journal: Clinical interventions in aging 20080601

Title: Summaries for patients. Drug therapy for osteoporosis.

Journal: Annals of internal medicine 20080506

Title: Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.

Journal: Annals of internal medicine 20080506

Title: Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period.

Journal: Annals of the rheumatic diseases 20080501

Title: Effects of risedronate on fracture risk in postmenopausal women with osteopenia.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501

Title: Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501

Title: Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.

Journal: Bone 20080501

Title: Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis.

Journal: Current medical research and opinion 20080501

Title: Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.

Journal: Current medical research and opinion 20080501

Title: Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies.

Journal: Bioorganic & medicinal chemistry letters 20080501

Title: Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.

Journal: Clinical therapeutics 20080501

Title: Can a disorder of the vestibular system underlie an etiology for migraine?

Journal: Ear, nose, & throat journal 20080501

Title: Osteoporotic fracture management in India: a survey of orthopaedic surgeons.

Journal: Journal of the Indian Medical Association 20080501

Title: Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20080401

Title: A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.

Journal: International journal of clinical practice 20080401

Title: In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications.

Journal: Current medical research and opinion 20080401

Title: Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20080401

Title: Osteonecrosis of the jaw: new developments in an old disease.

Journal: The Journal of rheumatology 20080401

Title: Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080401

Title: Fracture risk remains reduced one year after discontinuation of risedronate.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

Title: Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080301

Title: Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

Title: Preservation of periarticular cancellous morphology and mechanical stiffness in post-traumatic experimental osteoarthritis by antiresorptive therapy.

Journal: Clinical biomechanics (Bristol, Avon) 20080301

Title: Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

Title: A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.

Journal: Current medical research and opinion 20080301

Title: Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.

Journal: The Journal of rheumatology 20080301

Title: [Variance of expressions of extracellular matrix components and effects of anti-osteoporotic drugs on Mönckeberg's arteriosclerosis].

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080301

Title: [Radius shaft fracture in a 31-year old man].

Journal: Revista clinica espanola 20080201

Title: NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.

Journal: Journal of the American Chemical Society 20080130

Title: Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Journal: The Cochrane database of systematic reviews 20080123

Title: Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080101

Title: Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.

Journal: Bone 20080101

Title: The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis.

Journal: Journal of bone and mineral metabolism 20080101

Title: [Patient's preference for the daily and weekly bisphosphonate--evaluation from questionnaire of osteoporosis patients].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20080101

Title: Higher efficacy of urinary bone resorption marker measurements in assessing response to treatment for osteoporosis in postmenopausal women.

Journal: The Tohoku journal of experimental medicine 20080101

Title: [Guide for the prevention and treatment of glucocorticoid-induced osteoporosis of the Spanish Society of Internal Medicine].

Journal: Revista clinica espanola 20080101

Title: [Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy].

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20080101

Title: Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study.

Journal: Clinical drug investigation 20080101

Title: Efficacy of risedronate in Japanese male patients with primary osteoporosis.

Journal: Internal medicine (Tokyo, Japan) 20080101

Title: Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial.

Journal: Journal of bone and mineral metabolism 20080101

Title: Effect of risedronate on bone mass, remodelling and biomechanical strength in orchidectomized rats.

Journal: Hormone research 20080101

Title: Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy.

Journal: Scandinavian journal of clinical and laboratory investigation 20080101

Title: Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.

Journal: Menopause (New York, N.Y.) 20080101

Title: Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.

Journal: Anticancer research 20080101

Title: Analgesic and chondroprotective effects of risedronate in osteoarthritis assessed by electroalgometry and measurement of collagen type II fragments in urine.

Journal: The Journal of international medical research 20080101

Title: [Differences among bisfosfonates--specificity of risedronate (Actonel)].

Journal: Reumatizam 20080101

Title: Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.

Journal: BMC musculoskeletal disorders 20080101

Title: Medical treatment of otosclerosis: rationale for use of bisphosphonates.

Journal: The international tinnitus journal 20080101

Title: Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective.

Journal: Journal of medical economics 20080101

Title: Hip fractures in users of first- vs. second-generation bisphosphonates.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071201

Title: Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study.

Journal: Current medical research and opinion 20071201

Title: Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20071201

Title: Preventive effect of risedronate on bone loss in men receiving androgen-deprivation therapy for prostate cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association 20071201

Title: Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.

Journal: Minerva endocrinologica 20071201

Title: Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.

Journal: Journal of medicinal chemistry 20071129

Title: [HIP study--how to prevent hip fractures?].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128

Title: [FACT study].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128

Title: [Bisphosphonates for osteoporosis].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128

Title: [Evidence of risedronate for treatment of osteoporosis].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128

Title: [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128

Title: Risedronate did not block the maximal anabolic effect of PTH in aged rats.

Journal: Bone 20071101

Title: Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women.

Journal: Current medical research and opinion 20071101

Title: Isoprenoid-independent pathway is involved in apoptosis induced by risedronate, a bisphosphonate, in which Bim plays a critical role in breast cancer cell line MCF-7.

Journal: Oncology reports 20071101

Title: Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071101

Title: Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.

Journal: Expert opinion on pharmacotherapy 20071101

Title: The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids.

Journal: Arthritis and rheumatism 20071101

Title: Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001

Title: Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.

Journal: The journal of obstetrics and gynaecology research 20071001

Title: Osteoporosis: non-hormonal treatment.

Journal: Climacteric : the journal of the International Menopause Society 20071001

Title: [Osteoporosis in the patients with rheumatoid arthritis (3) : the efficacy and the selection of the osteoporosis therapeutic drug].

Journal: Clinical calcium 20071001

Title: Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.

Journal: Journal of endocrinological investigation 20071001

Title: Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.

Journal: Journal of periodontology 20070901

Title: Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients.

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070901

Title: Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Journal: Clinical therapeutics 20070901

Title: Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.

Journal: Clinical interventions in aging 20070901

Title: Yearly zoledronic acid in postmenopausal osteoporosis.

Journal: The New England journal of medicine 20070816

Title: Weekly risedronate in kidney transplant patients with osteopenia.

Journal: Transplant international : official journal of the European Society for Organ Transplantation 20070801

Title: Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.

Journal: Calcified tissue international 20070801

Title: Oral bisphosphonate associated osteonecrosis of the jaws: three case reports.

Journal: British dental journal 20070728

Title: Is cortical bone hip? What determines cortical bone properties?

Journal: Bone 20070701

Title: Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070701

Title: [Osteoporosis treatment: choices and options].

Journal: Polskie Archiwum Medycyny Wewnetrznej 20070701

Title: Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070601

Title: Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070601

Title: Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.

Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070601

Title: Pharmacological treatment of osteoporosis for people over 70.

Journal: Aging clinical and experimental research 20070601

Title: The futility of current approaches to chondroprotection.

Journal: Arthritis and rheumatism 20070501

Title: Bisphosphonates. A cornerstone of osteoporosis treatment.

Journal: Mayo Clinic women's healthsource 20070501

Title: Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.

Journal: Bone 20070401

Title: Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis.

Journal: The Journal of clinical endocrinology and metabolism 20070401

Title: [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].

Journal: Clinical calcium 20070401

Title: Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.

Journal: Experimental animals 20070401

Title: [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].

Journal: MMW Fortschritte der Medizin 20070329

Title: Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.

Journal: Neurology 20070320

Title: Effect of administration site in the gastrointestinal tract on bioavailability of poorly absorbed drugs taken after a meal.

Journal: Journal of controlled release : official journal of the Controlled Release Society 20070312

Title: Risedronate for the prevention of hip fractures: concern about validity of trials.

Journal: Archives of internal medicine 20070312

Title: Risedronate-induced Hepatitis.

Journal: The American journal of medicine 20070301

Title: Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance.

Journal: The American journal of medicine 20070301

Title: Osteochemonecrosis of jaws and bisphosphonates.

Journal: Irish medical journal 20070301

Title: Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations.

Journal: Analytica chimica acta 20070212

Title: Differential effects of bisphosphonates on breast cancer cell lines.

Journal: Cancer letters 20070208

Title: A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients.

Journal: Rheumatology (Oxford, England) 20070201

Title: Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis.

Journal: Archives of medical research 20070201

Title: Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070101

Title: Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial.

Journal: The Journal of clinical endocrinology and metabolism 20070101

Title: Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070101

Title: How long should patients take medications for postmenopausal osteoporosis?

Journal: Joint, bone, spine : revue du rhumatisme 20070101

Title: The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20070101

Title: Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian women.

Journal: Journal of bone and mineral metabolism 20070101

Title: Changes in bone resorption markers among Japanese patients with postmenopausal osteoporosis treated with alendronate and risedronate.

Journal: Journal of bone and mineral metabolism 20070101

Title: [The effect of risedronate treatment on bone turnover markers in patients with hip fracture].

Journal: Acta orthopaedica et traumatologica turcica 20070101

Title: The effect of alendronate, risedronate, and raloxifene on renal functions, based on the Cockcroft and Gault method, in postmenopausal women.

Journal: Renal failure 20070101

Title: Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.

Journal: Clinical and experimental rheumatology 20070101

Title: Bisphosphonates and osteonecrosis of the jaw: a retrospective study.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101

Title: Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention.

Journal: Journal of musculoskeletal & neuronal interactions 20070101

Title: A case of pachydermoperiostosis treated by oral administration of a bisphosphonate and arthroscopic synovectomy.

Journal: Modern rheumatology 20070101

Title: Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate.

Journal: Journal of bone and mineral metabolism 20070101

Title: Risedronate has no adverse effects on mouse haematopoiesis.

Journal: Folia biologica 20070101

Title: Safety considerations with bisphosphonates for the treatment of osteoporosis.

Journal: Drug safety 20070101

Title: Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases.

Journal: Hormones (Athens, Greece) 20070101

Title: High-dose bisphosphonate therapy in an urgent case of spontaneous multiple vertebral fractures in a 55 year old woman.

Journal: Wiener medizinische Wochenschrift (1946) 20070101

Title: Risedronate induced transient ocular myasthenia.

Journal: Journal of postgraduate medicine 20070101

Title: Effect of bisphosphonates on nitric oxide production by inflammatory activated chondrocytes.

Journal: Clinical and experimental rheumatology 20070101

Title: [Risedronate (Actonel)--from randomized clinical trials to real life].

Journal: Reumatizam 20070101

Title: Dehydration of risedronate hemi-pentahydrate: analytical and physical characterization.

Journal: Journal of pharmaceutical sciences 20061201

Title: European women's preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency.

Journal: Current medical research and opinion 20061201

Title: Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate.

Journal: Current medical research and opinion 20061201

Title: Bisphosphonates.

Journal: Annals of the New York Academy of Sciences 20061201

Title: Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol.

Journal: Journal of nutritional science and vitaminology 20061201

Title: [Men also need bone protection].

Journal: MMW Fortschritte der Medizin 20061116

Title: [Correlation between studies and general practice].

Journal: MMW Fortschritte der Medizin 20061116

Title: Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease.

Journal: Bone 20061101

Title: Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.

Journal: Bone 20061101

Title: Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.

Journal: Arthritis and rheumatism 20061101

Title: [Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis].

Journal: Clinical calcium 20061101

Title: Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users.

Journal: Pharmacoepidemiology and drug safety 20061001

Title: Is the increase in osteoporosis prevention a result of the audit?

Journal: Clinical neurology and neurosurgery 20061001

Title: Bisphosphonates activate nucleotide receptors signaling and induce the expression of Hsp90 in osteoblast-like cell lines.

Journal: Bone 20061001

Title: Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.

Journal: Bone 20061001

Title: Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.

Journal: Bone 20061001

Title: Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061001

Title: Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061001

Title: Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20061001

Title: Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.

Journal: Calcified tissue international 20061001

Title: Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.

Journal: Experimental animals 20061001

Title: Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.

Journal: Journal of nutritional science and vitaminology 20061001

Title: [A young woman with headaches and skull anomalies: a long road to the diagnosis 'Paget's disease'].

Journal: Nederlands tijdschrift voor geneeskunde 20060930

Title: Antioxidant effect of bisphosphonates and simvastatin on chondrocyte lipid peroxidation.

Journal: Biochemical and biophysical research communications 20060922

Title: Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells.

Journal: International journal of cancer 20060915

Title: Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.

Journal: Bone 20060901

Title: Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.

Journal: Bone 20060901

Title: [Therapeutic effects of risedronate on Paget's disease of bone].

Journal: Clinical calcium 20060901

Title: Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography.

Journal: Bone 20060801

Title: Chemical makeup of microdamaged bone differs from undamaged bone.

Journal: Bone 20060801

Title: Madarosis from mitochondriopathy.

Journal: Acta ophthalmologica Scandinavica 20060801

Title: Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years.

Journal: The Journal of clinical endocrinology and metabolism 20060701

Title: Anti-inflammatory and anti-nociceptive activity of risedronate in experimental pain models in rats and mice.

Journal: Clinical and experimental pharmacology & physiology 20060701

Title: Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060701

Title: Cost-effectiveness of alternative treatments for women with osteoporosis in Canada.

Journal: Current medical research and opinion 20060701

Title: Farnesyl diphosphate synthase is a cytosolic enzyme in Leishmania major promastigotes and its overexpression confers resistance to risedronate.

Journal: Eukaryotic cell 20060701

Title: Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.

Journal: Experimental animals 20060701

Title: Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.

Journal: Experimental animals 20060701

Title: [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].

Journal: MMW Fortschritte der Medizin 20060622

Title: Long-term experience with alendronate in the treatment of osteoporosis.

Journal: Expert opinion on pharmacotherapy 20060601

Title: Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting.

Journal: Southern medical journal 20060601

Title: Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosy.

Journal: Leprosy review 20060601

Title: Fracture prevention in postmenopausal women.

Journal: Clinical evidence 20060601

Title: The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.

Journal: Proceedings of the National Academy of Sciences of the United States of America 20060516

Title: [Only bone densitometry answers this question. How stable are your patients' bones?].

Journal: MMW Fortschritte der Medizin 20060504

Title: Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20060501

Title: Between-meal risedronate does not alter bone turnover in nursing home residents.

Journal: Journal of the American Geriatrics Society 20060501

Title: Osteoporosis in older people: a tale of two studies (and three treatments).

Journal: Journal of the American Geriatrics Society 20060501

Title: Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

Journal: Current medical research and opinion 20060501

Title: Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety.

Journal: Maturitas 20060420

Title: Preventing osteoporosis-related fractures: an overview.

Journal: The American journal of medicine 20060401

Title: Efficacy and acceptability of risedronate 5 mg daily compared with 35 mg once weekly for the treatment of postmenopausal osteoporosis.

Journal: Climacteric : the journal of the International Menopause Society 20060401

Title: Drug insight: Bisphosphonates for postmenopausal osteoporosis.

Journal: Nature clinical practice. Endocrinology & metabolism 20060401

Title: Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?

Journal: Nature clinical practice. Rheumatology 20060401

Title: Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis.

Journal: International journal of pharmaceutics 20060327

Title: Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.

Journal: Journal of the American Chemical Society 20060322

Title: Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study.

Journal: Rheumatology international 20060301

Title: Osteoporosis drug may protect joints.

Journal: Health news (Waltham, Mass.) 20060301

Title: Osteoporosis management in a Medicaid population after the Women's Health Initiative study.

Journal: Journal of women's health (2002) 20060301

Title: Potential adverse effects.

Journal: British dental journal 20060211

Title: Hospitalization-related bone loss and the protective effect of risedronate.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060201

Title: Pharmacological therapy of Paget's and other metabolic bone diseases.

Journal: Bone 20060201

Title: Patients with hip fracture: what can be improved?

Journal: Bone 20060201

Title: Strategies for the prevention and treatment of osteoporosis during early postmenopause.

Journal: American journal of obstetrics and gynecology 20060201

Title: [Application of anti-resorptive drugs for the treatment of osteoporosis].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20060201

Title: Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.

Journal: Journal of nutritional science and vitaminology 20060201

Title: Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.

Journal: Clinical therapeutics 20060201

Title: Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.

Journal: Rheumatology international 20060101

Title: Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design.

Journal: Proteins 20060101

Title: A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.

Journal: The American journal of gastroenterology 20060101

Title: Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

Title: Ophthalmological events in patients receiving risedronate: summary of information gained through follow-up in a prescription-event monitoring study in England.

Journal: Drug safety 20060101

Title: Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease.

Journal: Journal of bone and mineral metabolism 20060101

Title: [Your patients face the treatment of osteoporosis: How to improve the efficacy of management in clinical practice?].

Journal: La Revue du praticien 20060101

Title: Bisphosphonates are effective prophylactic of early bone loss after renal transplantation.

Journal: Transplantation proceedings 20060101

Title: Drug injury in the upper gastrointestinal tract: effects of alendronate.

Journal: Gastrointestinal endoscopy clinics of North America 20060101

Title: Challenges of recruitment of breast cancer survivors to a randomized clinical trial for osteoporosis prevention.

Journal: Cancer nursing 20060101

Title: The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

Title: Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study.

Journal: Acta orthopaedica Belgica 20060101

Title: Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

Title: Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence.

Journal: Drugs & aging 20060101

Title: Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen.

Journal: Journal of bone and mineral metabolism 20060101

Title: Medication persistence with weekly versus daily doses of orally administered bisphosphonates.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20060101

Title: A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometry.

Journal: Rapid communications in mass spectrometry : RCM 20060101

Title: Skeletal effects of short-term exposure to dexamethasone and response to risedronate treatment studied in vivo in rabbits by magnetic resonance micro-imaging and spectroscopy.

Journal: Journal of bone and mineral metabolism 20060101

Title: [Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature].

Journal: Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia 20060101

Title: Comparative therapeutic use of Risedronate and Calcarea phosphorica--allopathy versus homeopathy--in bone repair in castrated rats.

Journal: Brazilian oral research 20060101

Title: Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.

Journal: Drug safety 20060101

Title: Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international.

Journal: Clinical drug investigation 20060101

Title: Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis.

Journal: Advances in therapy 20060101

Title: [Treatment of osteoporosis by risedronate-- speed, efficacy and safety].

Journal: Reumatizam 20060101

Title: Paget's disease and bisphosphonates.

Journal: The New England journal of medicine 20051215

Title: Paget's disease and bisphosphonates.

Journal: The New England journal of medicine 20051215

Title: [Optimizing therapy in Paget disease].

Journal: MMW Fortschritte der Medizin 20051215

Title: One drug tackles two diseases.

Journal: British dental journal 20051210

Title: Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy.

Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20051201

Title: Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201

Title: Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051201

Title: Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20051201

Title: Prevention and treatment of glucocorticoid-induced osteoporosis in 2005.

Journal: Joint, bone, spine : revue du rhumatisme 20051201

Title: Symptomatic hypocalcemia due to oral risedronate therapy.

Journal: Indian journal of medical sciences 20051201

Title: [Examination and treatment of orthopedic-surgery patients with osteoporosis-related fragility fractures].

Journal: Ugeskrift for laeger 20051121

Title: Risedronate therapy for prevention of hip fracture after stroke in elderly women.

Journal: Neurology 20051108

Title: Risedronate-induced intravascular haemolysis complicated by acute tubular necrosis.

Journal: Clinical rheumatology 20051101

Title: [Practical approaches to the osteoporosis treatment--instructions for drug use that draws the effect of the medicine].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20051101

Title: [Antiresorptive treatment after proximal femur fracture].

Journal: Atencion primaria 20051101

Title: Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051001

Title: Madarosis from mitochondriopathy.

Journal: Acta ophthalmologica Scandinavica 20051001

Title: Upper gastrointestinal tract safety of daily oral risedronate in patients taking NSAIDs: a randomized, double-blind, placebo-controlled trial.

Journal: Mayo Clinic proceedings 20051001

Title: Review of treatment modalities for postmenopausal osteoporosis.

Journal: Southern medical journal 20051001

Title: Preparation and evaluation of floating risedronate sodium-Gelucire 43/01 formulations.

Journal: Drug development and industrial pharmacy 20051001

Title: Profound refractory hypocalcemia after thyroidectomy in a patient receiving chronic oral bisphosphonate therapy.

Journal: The American surgeon 20051001

Title: Monitoring of Risedronate by biochemical bone markers in clinical practice.

Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20051001

Title: Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050901

Title: Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050901

Title: High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse.

Journal: Bone 20050901

Title: Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

Journal: The New England journal of medicine 20050901

Title: Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.

Journal: Current medical research and opinion 20050901

Title: Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs.

Journal: Calcified tissue international 20050901

Title: [Risedronate: a possible treatment for extraosseous calcification].

Journal: Clinical calcium 20050901

Title: Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.

Journal: Climacteric : the journal of the International Menopause Society 20050901

Title: Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.

Journal: International journal of pharmaceutics 20050811

Title: Bisphosphonates stimulate an endogenous nonselective cation channel in Xenopus oocytes: potential mechanism of action.

Journal: American journal of physiology. Cell physiology 20050801

Title: Alendronate (Fosamax) and risedronate (Actonel) revisited.

Journal: Obstetrics and gynecology 20050801

Title: The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial.

Journal: Archives of internal medicine 20050801

Title: Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke.

Journal: Archives of internal medicine 20050801

Title: The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover.

Journal: Bone 20050701

Title: The use of bisphosphonates in the treatment of osteoporosis.

Journal: Current opinion in rheumatology 20050701

Title: Risedronate induced BOOP complicated with sarcoidosis.

Journal: Thorax 20050701

Title: Chronic diffuse sclerosing osteomyelitis treated with risedronate.

Journal: The Journal of rheumatology 20050701

Title: Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study.

Journal: Journal of periodontology 20050701

Title: Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B.

Journal: Biochemical pharmacology 20050615

Title: Risedronate in the treatment of Murine Chagas' disease.

Journal: Parasitology research 20050601

Title: A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

Journal: Health technology assessment (Winchester, England) 20050601

Title: Microcracks in cortical bone: how do they affect bone biology?

Journal: Current osteoporosis reports 20050601

Title: A bright future for osteoporosis treatment.

Journal: Drug news & perspectives 20050601

Title: [Marketing--alendronate versus risedronate].

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050519

Title: [To increase bone density faster and stronger].

Journal: MMW Fortschritte der Medizin 20050505

Title: Current pharmacological treatment for fibrous dysplasia and perspectives for the future.

Journal: Joint, bone, spine : revue du rhumatisme 20050501

Title: Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.

Journal: European journal of obstetrics, gynecology, and reproductive biology 20050501

Title: Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050501

Title: Alendronate (Fosamax) and risedronate (Actonel) revisited.

Journal: The Medical letter on drugs and therapeutics 20050425

Title: [Paget's disease and its therapeutic management].

Journal: Presse medicale (Paris, France : 1983) 20050423

Title: [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates].

Journal: MMW Fortschritte der Medizin 20050407

Title: [Excellent adjustment with greater action. To pay attention to improving compliance].

Journal: MMW Fortschritte der Medizin 20050407

Title: Structural and analytical characterization of three hydrates and an anhydrate form of risedronate.

Journal: Journal of pharmaceutical sciences 20050401

Title: Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data.

Journal: Aging clinical and experimental research 20050401

Title: Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice.

Journal: Biochemical and biophysical research communications 20050318

Title: Risedronate therapy for prevention of hip fracture after stroke in elderly women.

Journal: Neurology 20050308

Title: Oral antiresorptive therapy.

Journal: Current rheumatology reports 20050301

Title: Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment.

Journal: Bone 20050301

Title: Risedronate for prevention and treatment of osteoporosis in postmenopausal women.

Journal: Expert opinion on pharmacotherapy 20050301

Title: Glucocorticoid-induced osteoporosis: treatment options and guidelines.

Journal: Current osteoporosis reports 20050301

Title: [Pharmacological treatment of osteitis deformans (Paget's bone disease)].

Journal: Ugeskrift for laeger 20050227

Title: [Evaluation of the effects of treatment of osteoporosis].

Journal: Ugeskrift for laeger 20050227

Title: [Osteoporosis in the elderly--diagnosis and treatment].

Journal: MMW Fortschritte der Medizin 20050217

Title: Alendronate and risedronate: reports of severe bone, joint, and muscle pain.

Journal: Archives of internal medicine 20050214

Title: The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study.

Journal: Bone 20050201

Title: [FACT study: benefits of alendronate].

Journal: MMW Fortschritte der Medizin 20050113

Title: Extemporaneous procedures for dissolving risedronate tablets for oral administration and for feeding tubes.

Journal: The Annals of pharmacotherapy 20050101

Title: Trochanteric hip fracture in an elderly patient with leprosy during osteoporosis treatment with risedronate and alfacalcidol.

Journal: Journal of bone and mineral metabolism 20050101

Title: Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050101

Title: Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050101

Title: Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.

Journal: Treatments in endocrinology 20050101

Title: Interleukin-18 (IL-18) and matrix metalloproteinase-9 (MMP-9) in post-menopausal osteoporosis.

Journal: Archives of gerontology and geriatrics 20050101

Title: Structure-activity relationships of a new class of aromatic bisphosphonates that inhibit tumor cell proliferation in vitro.

Journal: Anticancer research 20050101

Title: Chondrosarcoma in Paget's disease of bone.

Journal: Clinical and experimental rheumatology 20050101

Title: Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173].

Journal: Arthritis research & therapy 20050101

Title: Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.

Journal: Treatments in endocrinology 20050101

Title: Systemic effects of fluticasone nasal spray: report of 2 cases.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101

Title: Effects of risedronate on femoral bone mineral density and bone strength in sciatic neurectomized young rats.

Journal: Journal of bone and mineral metabolism 20050101

Title: Periodontal assessment of postmenopausal women receiving risedronate.

Journal: Menopause (New York, N.Y.) 20050101

Title: Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis.

Journal: Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20050101

Title: [What do we need to know--what can we do?].

Journal: Krankenpflege Journal 20050101

Title: Seven years of treatment with risedronate in women with postmenopausal osteoporosis.

Journal: Calcified tissue international 20041201

Title: Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis.

Journal: Calcified tissue international 20041201

Title: Pharmaceutical care and community pharmacists' understanding of bisphosphonate dosing information.

Journal: Journal of clinical pharmacy and therapeutics 20041201

Title: Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis.

Journal: Current medical research and opinion 20041201

Title: Oral antiresorptive therapy.

Journal: Current osteoporosis reports 20041201

Title: Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20041101

Title: Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

Journal: Journal of the American Geriatrics Society 20041101

Title: Pharmacologic prevention of osteoporotic fractures.

Journal: American family physician 20041001

Title: Treating osteoporosis in post-menopausal women: a case approach.

Journal: Cleveland Clinic journal of medicine 20041001

Title: New treatments for brittle bones.

Journal: Annals of internal medicine 20040907

Title: Coming to grips with bone loss.

Journal: Science (New York, N.Y.) 20040903

Title: Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.

Journal: Calcified tissue international 20040901

Title: Antiresorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee.

Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040901

Title: Fracture protection in osteoporosis with risedronate.

Journal: Hospital medicine (London, England : 1998) 20040901

Title: [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show].

Journal: Praxis 20040901

Title: Preparation and evaluation of floating risedronate sodium Gelucire 39/01 matrices.

Journal: Acta pharmaceutica (Zagreb, Croatia) 20040901

Title: [Stability also depends on other parameters. Bone density--not a good indicator for fracture prevention].

Journal: MMW Fortschritte der Medizin 20040805

Title: [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].

Journal: MMW Fortschritte der Medizin 20040805

Title: Osteoblast proliferation and maturation by bisphosphonates.

Journal: Biomaterials 20040801

Title: The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits.

Journal: Bone 20040801

Title: Effects of risedronate on bone density in anorexia nervosa.

Journal: The Journal of clinical endocrinology and metabolism 20040801

Title: Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.

Journal: Current oncology reports 20040701

Title: Prevention of glucocorticoid-induced osteoporosis.

Journal: Southern medical journal 20040601

Title: [Faster and long-lasting protection with risedronate. With strengthened bones longer self-sufficient].

Journal: MMW Fortschritte der Medizin 20040527

Title: [Risedronate affects bone strength, too. Faster protective effect on microarchitecture].

Journal: MMW Fortschritte der Medizin 20040527

Title: [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].

Journal: MMW Fortschritte der Medizin 20040520

Title: Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate.

Journal: Journal of gastroenterology and hepatology 20040501

Title: Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.

Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040501

Title: Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis.

Journal: Current medical research and opinion 20040501

Title: Contribution of Complementarity-Determining Region 3 of the T-Cell Receptor Vδ2 Chain to the Recognition of Aminobisphosphonates by Human γδ T-Cells.

Journal: International journal of hematology 20040501

Title: [Bone quality in treatment with raroxifene ].

Journal: Clinical calcium 20040501

Title: Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.

Journal: Bone 20040401

Title: Efficacy of risedronate on clinical vertebral fractures within six months.

Journal: Current medical research and opinion 20040401

Title: Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi.

Journal: International journal of antimicrobial agents 20040301

Title: Antiparasitic activity of risedronate in a murine model of acute Chagas' disease.

Journal: International journal of antimicrobial agents 20040301

Title: [Data comparison of osteoporosis patients demonstrates nasal administration is not optimal].

Journal: MMW Fortschritte der Medizin 20040212

Title: Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis.

Journal: Calcified tissue international 20040201

Title: An update on bisphosphonates.

Journal: Current rheumatology reports 20040201

Title: Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040201

Title: [New guideline for the treatment of osteoporosis].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20040201

Title: [Risedronate treatment for osteoporosis].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20040201

Title: [VERT(Vertebral Efficacy with Risedronate Therapy)-MN(Multinational) Study and VERT-NA(North America) Study].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20040201

Title: [Combination therapy of bisphosphonate and estrogen for osteoporosis].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20040201

Title: The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment.

Journal: Alcoholism, clinical and experimental research 20040101

Title: Clinical trial of risedronate in Japanese volunteers: single and multiple oral dose studies.

Journal: Journal of bone and mineral metabolism 20040101

Title: Clinical trial of risedronate in Japanese volunteers: a study on the effects of timing of dosing on absorption.

Journal: Journal of bone and mineral metabolism 20040101

Title: Comparison of risedronate to alendronate and calcitonin for early reduction of nonvertebral fracture risk: results from a managed care administrative claims database.

Journal: Journal of managed care pharmacy : JMCP 20040101

Title: Parathyroid hormone.

Journal: The Journal of the American Academy of Orthopaedic Surgeons 20040101

Title: Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.

Journal: European review for medical and pharmacological sciences 20040101

Title: Markers of bone resorption in bisphosphonate therapy of Paget's disease.

Journal: Clinical and experimental rheumatology 20040101

Title: [Consistent therapeutic success in osteoporosis].

Journal: Krankenpflege Journal 20040101

Title: Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.

Journal: Journal of bone and mineral metabolism 20040101

Title: A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial.

Journal: Journal of bone and mineral metabolism 20040101

Title: Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20040101

Title: Alendronate and risedronate for the treatment of postmenopausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations.

Journal: MedGenMed : Medscape general medicine 20040101

Title: Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Journal: International journal of clinical pharmacology research 20040101

Title: [Update 2004. Osteoporosis--management--current status].

Journal: Krankenpflege Journal 20040101

Title: [Routine osteoporosis therapy].

Journal: Krankenpflege Journal 20040101

Title: Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study.

Journal: International journal of clinical pharmacology research 20040101

Title: Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.

Journal: Endocrinology 20031201

Title: Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031201

Title: Spectrophotometric determination of some drugs for osteoporosis.

Journal: Chemical & pharmaceutical bulletin 20031201

Title: A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20031201

Title: Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs.

Journal: Bone 20031201

Title: Patent news.

Journal: IDrugs : the investigational drugs journal 20031201

Title: An approach to postmenopausal osteoporosis treatment: a case study review.

Journal: Journal of the American Academy of Nurse Practitioners 20031201

Title: Osteoporosis management in the new millennium.

Journal: Primary care 20031201

Title: Use of highly potent bisphosphonates in the treatment of osteoporosis.

Journal: Current osteoporosis reports 20031201

Title: Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography.

Journal: Calcified tissue international 20031101

Title: Aging bone and osteoporosis: strategies for preventing fractures in the elderly.

Journal: Archives of internal medicine 20031013

Title: Determination of risedronate in human urine by column-switching ion-pair high-performance liquid chromatography with ultraviolet detection.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030825

Title: [Evidence-based therapy of osteoporosis--comment on DMW 17/2003].

Journal: Deutsche medizinische Wochenschrift (1946) 20030725

Title: Bisphosphonates: new indications and methods of administration.

Journal: Current opinion in rheumatology 20030701

Title: Show us the numbers.

Journal: Canadian family physician Medecin de famille canadien 20030701

Title: [Therapy of osteoporosis with bisphosphonate. Bone quality maintained over years].

Journal: MMW Fortschritte der Medizin 20030605

Title: Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030601

Title: Identifying the osteopenic patient and preventing worsening of the disease.

Journal: Current women's health reports 20030601

Title: Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030601

Title: Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates.

Journal: Calcified tissue international 20030601

Title: [To treat effectively without delay. The data on fractures decisive].

Journal: MMW Fortschritte der Medizin 20030522

Title: [For patients with osteoporosis-induced fracture the emergency brake must be pulled. Every 4th patient as a recurrence in the following year].

Journal: MMW Fortschritte der Medizin 20030508

Title: Tolerability and compliance with risedronate in clinical practice.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030501

Title: A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group).

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030501

Title: [Osteoporosis in men].

Journal: Deutsche medizinische Wochenschrift (1946) 20030425

Title: Involvement of vacuolar H+ -ATPase in incorporation of risedronate into osteoclasts.

Journal: Bone 20030401

Title: Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.

Journal: Canadian family physician Medecin de famille canadien 20030401

Title: [Osteoporosis therapy. Bisphosphonates compared].

Journal: MMW Fortschritte der Medizin 20030327

Title: [Vertebral body fracture as incidental finding in thoracic radiography. Family physician usually does not learn about it].

Journal: MMW Fortschritte der Medizin 20030220

Title: Effects of risedronate, alendronate, and etidronate on the viability and activity of rat bone marrow stromal cells in vitro.

Journal: Calcified tissue international 20030201

Title: Editorial: greater risk, greater benefit--true or false?

Journal: The Journal of clinical endocrinology and metabolism 20030201

Title: Risedronate prevents new vertebral fractures in postmenopausal women at high risk.

Journal: The Journal of clinical endocrinology and metabolism 20030201

Title: Three hydrates of the bisphosphonate risedronate, consisting of one molecular and two ionic structures.

Journal: Acta crystallographica. Section C, Crystal structure communications 20030201

Title: [Effects of bisphosphonate on trabecular microstructure].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20030201

Title: [Risedronate].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20030201

Title: [Treatment of osteoporosis provided from the orthopaedic surgeon's standpoint].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20030201

Title: Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa.

Journal: Digestive diseases and sciences 20030201

Title: [Economic assessment based on a clinical study of risedronate. Fracture prevention in elderly women with osteoporosis is cost-effective].

Journal: Lakartidningen 20030109

Title: Bone density changes with once weekly risedronate in postmenopausal women.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20030101

Title: Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis.

Journal: International journal of fertility and women's medicine 20030101

Title: Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study.

Journal: Current medical research and opinion 20030101

Title: Risedronate for the prevention and treatment of postmenopausal osteoporosis.

Journal: The Cochrane database of systematic reviews 20030101

Title: [Bisphosphonates in the prevention of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis].

Journal: Reumatizam 20030101

Title: Pharmacoeconomic analysis of osteoporosis treatment with risedronate.

Journal: International journal of clinical pharmacology research 20030101

Title: Risedronate once a week.

Journal: Treatments in endocrinology 20030101

Title: A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20021201

Title: Medications for postmenopausal osteoporosis prevention.

Journal: Harvard women's health watch 20021201

Title: Risedronate prevents hip fractures, but who should get therapy?

Journal: Cleveland Clinic journal of medicine 20021201

Title: [Osteoporosis].

Journal: Der Internist 20021201

Title: Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

Journal: Cancer research 20021115

Title: Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis.

Journal: Bone 20021101

Title: [Weeks of pain, vertebral body fractures during sleep, invalidism. Save your osteoporosis patients from this fate].

Journal: MMW Fortschritte der Medizin 20021031

Title: Once-a-week risedronate (actonel).

Journal: The Medical letter on drugs and therapeutics 20021014

Title: Bisphosphonates and the upper gastrointestinal tract: skeletal gain without visceral pain?

Journal: Mayo Clinic proceedings 20021001

Title: [Treatment of osteoporosis. Not only measurements count].

Journal: MMW Fortschritte der Medizin 20020905

Title: 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.

Journal: The Journal of rheumatology 20020901

Title: Bisphosphonates.

Journal: Maturitas 20020830

Title: Commentary on: Bone mineral density and fracture prevalence in long-term kidney graft recipients.

Journal: Transplantation 20020827

Title: The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis.

Journal: Calcified tissue international 20020801

Title: Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020801

Title: What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.

Journal: Digestive diseases and sciences 20020801

Title: Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis.

Journal: Endocrine reviews 20020801

Title: Osteoporosis in elderly: prevention and treatment.

Journal: Clinics in geriatric medicine 20020801

Title: [Osteoporosis therapy. A comparison of bisphosphonates].

Journal: MMW Fortschritte der Medizin 20020711

Title: Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.

Journal: Endocrinology 20020701

Title: Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020701

Title: Bone quality: getting closer to a definition.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020701

Title: Assessment of mortality in patients enrolled in a risedronate clinical trial program: a retrospective cohort study.

Journal: Regulatory toxicology and pharmacology : RTP 20020601

Title: Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020528

Title: The cost utility of bisphosphonate treatment in established osteoporosis.

Journal: QJM : monthly journal of the Association of Physicians 20020501

Title: Risedronate: a new oral bisphosphonate.

Journal: Clinical therapeutics 20020501

Title: [Episcleritis secondary to risedronate].

Journal: Medicina clinica 20020427

Title: [When osteoporosis first manifests itself. Without therapy the next fracture threatens].

Journal: MMW Fortschritte der Medizin 20020404

Title: Risedronate for the prevention of fractures in postmenopausal osteoporosis.

Journal: The Annals of pharmacotherapy 20020401

Title: [Risedronate, a new diphosphonate in osteoporosis and Paget's disease].

Journal: Presse medicale (Paris, France : 1983) 20020302

Title: Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials.

Journal: Mayo Clinic proceedings 20020301

Title: Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis.

Journal: The Annals of pharmacotherapy 20020301

Title: [Risedronate: clinical usage].

Journal: Nihon rinsho. Japanese journal of clinical medicine 20020301

Title: The underuse of therapy in the secondary prevention of hip fractures.

Journal: Drugs & aging 20020101

Title: Risedronate reduces the risk of first vertebral fracture in osteoporotic women.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020101

Title: Response of bone mineral density to once-weekly administration of risedronate.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20020101

Title: Alendronate and risedronate: what you need to know about their upper gastrointestinal tract toxicity.

Journal: Reviews in gastroenterological disorders 20020101

Title: Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review.

Journal: Drug safety 20020101

Title: A review of combination regimens for osteoporosis--prevention and treatment.

Journal: International journal of fertility and women's medicine 20020101

Title: [Osteoporosis: diagnosis, prevention and treatment].

Journal: Medicina (Kaunas, Lithuania) 20020101

Title: [Osteoporosis: diagnosis and treatment of vertebral fractures].

Journal: Medicina (Kaunas, Lithuania) 20020101

Title: Prevention and treatment of osteoporosis.

Journal: Clinical cornerstone 20020101

Title: [Therapy of osteoporosis. Risk factors alone are not an indication].

Journal: MMW Fortschritte der Medizin 20011206

Title: Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.

Journal: Bone 20011201

Title: Review of risedronate in the treatment of osteoporosis.

Journal: Expert opinion on pharmacotherapy 20011201

Title: Risedronate for the prevention and treatment of postmenopausal osteoporosis: results from recent clinical trials.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20011201

Title: [Economic aspects of osteoporosis therapy. What does a prevented fracture cost?].

Journal: MMW Fortschritte der Medizin 20011122

Title: A method to assess the proportion of treatment effect explained by a surrogate endpoint.

Journal: Statistics in medicine 20011115

Title: Role of alendronate and risedronate in preventing and treating osteoporosis.

Journal: Cleveland Clinic journal of medicine 20011101

Title: Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage.

Journal: Calcified tissue international 20011101

Title: [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].

Journal: Gynecologie, obstetrique & fertilite 20011101

Title: [Osteoporosis. Fracture as alarm signal].

Journal: MMW Fortschritte der Medizin 20011011

Title: Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.

Journal: Bone 20011001

Title: Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.

Journal: Calcified tissue international 20011001

Title: Tolerability of risedronate in postmenopausal women intolerant of alendronate.

Journal: Aging (Milan, Italy) 20011001

Title: Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.

Journal: The Journal of biological chemistry 20010907

Title: [Optimizing treatment of osteoporosis. Rapidly effective therapy lowers fracture risk in 1 year up to 70%].

Journal: MMW Fortschritte der Medizin 20010906

Title: [Risedronate now also approved for hip fractures. Study discloses significant risk reduction in proximal femoral neck fractures].

Journal: MMW Fortschritte der Medizin 20010906

Title: Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates.

Journal: Blood 20010901

Title: Pharmacologic therapy for the treatment and prevention of osteoporosis.

Journal: The Nursing clinics of North America 20010901

Title: Bisphosphonates for osteoporosis.

Journal: Drug and therapeutics bulletin 20010901

Title: Risedronate: a new oral bisphosphonate.

Journal: Clinical therapeutics 20010901

Title: Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature.

Journal: Obstetrical & gynecological survey 20010801

Title: The in-vitro porcine adhesion model is not predictive of the esophageal transit of risedronate tablets in humans.

Journal: International journal of pharmaceutics 20010717

Title: The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water.

Journal: International journal of pharmaceutics 20010717

Title: [Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures].

Journal: Nederlands tijdschrift voor geneeskunde 20010714

Title: [Fluorides and bisphosphonates in the treatment of osteoporosis].

Journal: Der Orthopade 20010701

Title: (31)P NMR of apicomplexans and the effects of risedronate on Cryptosporidium parvum growth.

Journal: Biochemical and biophysical research communications 20010615

Title: Osteoporosis in men.

Journal: American family physician 20010615

Title: Re: Lanza et al.--Endoscopic comparison of alendronate and risedronate.

Journal: The American journal of gastroenterology 20010601

Title: The effect of risedronate on the risk of hip fracture in elderly women.

Journal: The New England journal of medicine 20010531

Title: The effect of risedronate on the risk of hip fracture in elderly women.

Journal: The New England journal of medicine 20010531

Title: The effect of risedronate on the risk of hip fracture in elderly women.

Journal: The New England journal of medicine 20010531

Title: Absolute vs. relative numbers in evaluating drug therapy.

Journal: American family physician 20010515

Title: [Bisphosphonates in osteoporosis. Significantly reduces risk of fracture].

Journal: MMW Fortschritte der Medizin 20010503

Title: The role of combination treatment for osteoporosis.

Journal: The Journal of clinical endocrinology and metabolism 20010501

Title: Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.

Journal: The Journal of clinical endocrinology and metabolism 20010501

Title: Risedronate: clinical usage.

Journal: International journal of clinical practice 20010501

Title: Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.

Journal: Clinical therapeutics 20010401

Title: Once-a-week alendronate (Fosamax).

Journal: The Medical letter on drugs and therapeutics 20010319

Title: Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats.

Journal: Bone 20010301

Title: Hip fractures: do preventive drugs work for all?

Journal: Health news (Waltham, Mass.) 20010301

Title: Evidence-based medicine: putting theory into practice.

Journal: Hospital medicine (London, England : 1998) 20010301

Title: Risedronate: a clinical review.

Journal: Archives of internal medicine 20010212

Title: Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

Journal: The New England journal of medicine 20010201

Title: Treatment of osteoporosis with bisphosphonates.

Journal: Rheumatic diseases clinics of North America 20010201

Title: Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration.

Journal: Pharmaceutical research 20010201

Title: Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects.

Journal: Alimentary pharmacology & therapeutics 20010101

Title: Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis.

Journal: Bone 20010101

Title: Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.

Journal: Clinical and experimental rheumatology 20010101

Title: Prevention and treatment of osteoporosis.

Journal: Clinical medicine (London, England) 20010101

Title: Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.

Journal: Drugs 20010101

Title: Risedronate treatment and extended fracture protection in postmenopausal women.

Journal: Clinical and experimental rheumatology 20010101

Title: Osteoporosis in men.

Journal: Orthopedic nursing 20010101

Title: Comparison insight dual X-ray absorptiometry (DXA), histomorphometry, ash weight, and morphometric indices for bone evaluation in an animal model (the orchidectomized rat) of male osteoporosis.

Journal: Calcified tissue international 20010101

Title: [Patients with fractures are in the front line for osteoporosis treatment but how to treat?].

Journal: Duodecim; laaketieteellinen aikakauskirja 20010101

Title: Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19980401

Title: Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.

Journal: The Journal of clinical endocrinology and metabolism

Title: Giljevic Z, et al. Treatment of osteoporosis by risedronate-- speed, efficacy and safety. Reumatizam. 2006;53(2):66-71.

Title: Jordao FM, et al. In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum. Antimicrob Agents Chemother. 2011 May;55(5):2026-31.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 115436-72-1
Tags:115436-72-1 Molecular Formula|115436-72-1 MDL|115436-72-1 SMILES|115436-72-1 sodium hydrogen [1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonate